Cochlear Limited (Cochlear), an implantable hearing solutions company, announced the introduction of three new technologies- Cochlear Hybrid, Cochlear Nucleus 5 and Cochlear Baha BP 100 in India, the Press Trust of India reported. This implantable hearing technologies are designed for the patients suffering from partial deafness, moderate to profound deafness and single-sided deafness.
Cochlear implant technology could benefit more than 3-million children and adults in India who are currently living in silence, Cochlear’s President Asia-Pacific, Mark Salmon, said.
Cochlear implant technology could benefit more than 3-million children and adults in India who are currently living in silence, Cochlear’s President Asia-Pacific, Mark Salmon, said.
Today, more than 1,80,000 deaf adults and children across the globe have acquired language and listening schools with implantable hearing technology, Salmon said.
The fifth-generation implant technolgy would cost Rs5.3-lakh (INR0.53 million) at the lower-end and Rs 9.50-lakh (INR0.95 million) at the higher-end, Cochlear’s Country Manager-India and Regional Head-South Asia, Rajiv Gatne, said.
The company will offer implant surgeries at 40 centres across the country. The company has successfully conducted 3,500 implant surgeries in the last 10-years in India, Gatne said.